12 results on '"İsmihan Sunar"'
Number of results to display per page
Search Results
2. Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?
- Author
-
Duygu Tecer, Ismihan Sunar, Ali Erhan Ozdemirel, Rabia Tural, Orhan Kucuksahin, Aylin Sepici Dincel, and Sebnem Ataman
- Subjects
Atherogenic indexes ,Atherosclerosis ,Ca-LDL ,Carotid intima-media thickness ,Psoriatic arthritis ,Diseases of the musculoskeletal system ,RC925-935 ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Abstract Background To investigate the link between carbamylated low-density lipoprotein (ca-LDL), atherogenic index of plasma (AIP), atherogenic coefficient (AC), Castelli’s risk indices I and II (CRI I and II) and subclinic atherosclerosis in psoriatic arthritis (PsA). Methods Thirty-ninepatients and 19 age, sex, body mass index matched healthy controls were included. Insulin resistance (IR) was assessed with homeostasis of model assessment-IR (HOMA-IR). Carotid intima-media thickness (CIMT) was measured at both common carotid arteries and mean CIMT was calculated. Results The mean age was 49.50 ± 11.86 years and 64.1% were females in PsA group. In the PsA group, CIMT and HOMA-IR were significantly higher (p = 0.003, p = 0.043, respectively). AIP, AC, TG/HDL, CRI-1, CRI-2 and ca-LDL levels were similar between groups. In PsA group, CIMT was positively correlated with HOMA-IR, TG/HDL and AIP. Although ca-LDL was positively correlated with serum amyloid A (r = 0.744, p
- Published
- 2019
- Full Text
- View/download PDF
3. Inconsistencies of the Disease Activity Assessment Tools for Psoriatic Arthritis: Challenges to Rheumatologists
- Author
-
Mustafa Çaliş, Murat Toprak, Halise Hande Gezer, Hatice Bodur, Cevriye Mülkoğlu, Fikriye Figen Ayhan, Nihan Cuzdan, Oznur Kutluk, Ajda Bal, Nilay Sahin, Gizem Cengiz, Tiraje Tuncer, İbrahim Tekeoğlu, Sena Tolu, Ilknur Albayrak Gezer, Betul Sargin, Meltem Alkan Melikoglu, Sami Hizmetli, Nesrin Şen, Sevtap Acer Kasman, Hakan Alkan, Dilek Keskin, Kevser Gok, Yaşar Keskin, Gul Devrimsel, Erhan Capkin, Ayhan Kamanli, Erkan Kilic, Okan Küçükakkaş, Hilal Ecesoy, Mehmet Tuncay Duruöz, Ömer Faruk Şendur, Ozan Volkan Yurdakul, Hatice Reşorlu, İsmihan Sunar, Merve Baykul, Kemal Nas, and KESKİN, Yaşar
- Subjects
Male ,Disease ,physical examination ,Severity of Illness Index ,middle aged ,Health Assessment Questionnaire ,rheumatologist ,skin and connective tissue diseases ,disease activity score ,Disease Activity in Psoriatic Arthritis ,adult ,Fibromyalgia Rapid Screening Tool ,Remission Induction ,Swollen joints ,anxiety ,Peripheral ,Hospital Anxiety and Depression Scale ,female ,low disease activity ,Treatment Outcome ,Antirheumatic Agents ,depression ,joint swelling ,medicine.symptom ,enthesopathy ,musculoskeletal diseases ,medicine.medical_specialty ,dactylitis ,Remission ,Psoriatic Arthritis ,Challenges to Rheumatologists.-, Joint bone spine, ss.105296, 2021 [Gezer H. H. , Duruöz M. T. , Nas K., Kılıç E., Sargın B., Kasman S. A. , Alkan H., Şahin N., Cengiz G., Cüzdan N., et al., -Inconsistencies of the Disease Activity Assessment Tools for Psoriatic Arthritis] ,prostate specific antigen ,patient-reported outcome ,Article ,rate of remission ,Disease activity ,Psoriatic arthritis ,Rheumatology ,Internal medicine ,medicine ,diverse activity scale ,DAS28 ,Humans ,In patient ,controlled study ,human ,Disease Activity ,clinical assessment tool ,Composite Index ,business.industry ,enthesitis ,Arthritis, Psoriatic ,Enthesitis ,visual analog scale ,clinical assessment ,very low disease activity ,Prostate-Specific Antigen ,medicine.disease ,major clinical study ,antirheumatic agent ,minimal disease activity ,fatigue ,disease duration ,Rheumatologists ,business ,Rheumatism - Abstract
Objective: Currently, concerning the evaluation of psoriatic arthritis (PsA), there is no agreement on a standardized composite index for disease activity that includes all relevant domains. The present study sought to assess the rates of remission (REM)/low disease activity (LDA) and disease states [minimal disease activity (MDA), very low disease activity (VLDA)] as defined by diverse activity scales (DAPSA, DAS28-ESR) in an attempt to display discrepancies across these assessment tools for peripheral PsA. Methods: The study involved 758 patients (496 females, 262 males; mean age 47,1 years) with peripheral PsA who were registered to the Turkish League Against Rheumatism (TLAR) Network. The patients were assessed using the DAS28-ESR, DAPSA, MDA, and VLDA. The overall yield of each scale was assessed in identifying REM and LDA. The presence or absence of swollen joints was separately analysed. Results: The median disease duration was 4 years (range 0-44 years). According to DAPSA and DAS28-ESR, REM was achieved in 6.9% and 19.5% of the patients, respectively. The rates of MDA and VLDA were 16% and 2.9%, respectively. Despite the absence of swollen joints, a significant portion of patients were not considered to be in REM (296 (39.1%) patients with DAS28-ESR, 364 (48%) with DAPSA, and 394 (52%) with VLDA). Conclusion: Patients with peripheral PsA may be assigned to diverse disease activity levels when assessed with the DAS28-ESR, DAPSA, MDA and VLDA, which would inevitably have clinical implications. In patients with PsA a holistic approach seems to be necessary which includes other domains apart from joint involvement, such as skin involvement, enthesitis, spinal involvement, and patient-reported outcomes. © 2021 Société française de rhumatologie
- Published
- 2022
4. Demographic and clinical characteristics of patients with sustained and switching treatments using biological and targeted synthetic disease-modifying antirheumatic drugs: A multicenter, observational cross-sectional study for rheumatoid arthritis
- Author
-
Remzi Çevik, Ozgur Akgul, Gülcan Gürer, Şebnem Ataman, Mehmet Tuncay Duruöz, Ayhan Kamanli, Feride Gogus, Aylin Rezvani, Fatma Gül Yurdakul, Ilker Yagci, Erhan Capkin, Hasan Fatih Çay, İsmihan Sunar, Hatice Bodur, Meltem Alkan Melikoglu, Ataman, Sebnem, Sunar, Ismihan, Bodur, Hatice, Melikoglu, Meltem Alkan, Cay, Hasan Fatih, Capkin, Erhan, Akgul, Ozgur, Cevik, Remzi, Gogus, Feride, Kamanli, Ayhan, Yurdakul, Fatma Gul, Gurer, Gulcan, Yagci, Ilker, Rezvani, Aylin, Duruoz, Mehmet Tuncay, Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fizik Tedavi ve Rehabilitasyon Ana Bilim Dalı, and Çevik, Remzi
- Subjects
Drug ,medicine.medical_specialty ,Cross-sectional study ,Treatment Switching ,media_common.quotation_subject ,Rheumatoid Arthritis ,Disease ,AMERICAN-COLLEGE ,THERAPY ,Rheumatology ,RHEUMATOLOGY/EUROPEAN LEAGUE ,Internal medicine ,Epidemiology ,medicine ,MANAGEMENT ,Immunology and Allergy ,Treatment switching ,Registries ,Rheumatoid arthritis ,media_common ,RISK ,business.industry ,REMISSION RATES ,medicine.disease ,Diseasemodifying Antirheumatic Drugs ,SAFETY ,Cohort ,Observational study ,Disease-modifying antirheumatic drugs ,business - Abstract
Introduction Rheumatoid arthritis is a chronic inflammatory disease with different disease activity grades. Several registries have been designed to determine the appropriate regimens of disease-modifying antirheumatic drugs to obtain sustained clinical remission. We examined epidemiological and clinical characteristics of rheumatoid arthritis patients using a clinical registry database (BioSTaR) and analyzed the differences in patients with sustained and switched therapies. Methods A multicenter, observational cross-sectional study for rheumatoid arthritis was performed between February 2019 and September 2020 using the BioStaR-RA registry. Demographic and clinical characteristics were prospectively recorded into a specifically designed electronic database. The patients were divided into three groups due to the heterogeneity of the study cohort. Patients were grouped as Group I (Initial; within the first 6 months of treatment with biological/targeted synthetic drugs), Group ST (Sustained Treatment; any first drug lasting for at least 6 months without any change), and Group S (Switch; any switching to another drug). Comparative analysis was performed between sustained treatment (Group ST) and drug switching (Group S) groups. Results The study included a total of 565 patients. The mean age was 53.7 +/- 12.8 years, and the majority were female (80.4%). There were 104, 267, and 194 patients in Groups I, ST, and S, respectively. Erosive arthritis and hematological extra-articular involvement were more frequently detected in Group S than Group ST (p = 0.009 and p = 0.001). The patients in Group S had significantly higher disease activity scores (DAS28-CRP, CDAI, and SDAI) (p = 0.025, p = 0.010, and p = 0.003). There were significantly more patients with moderate disease activity in Group S (p < 0.05). Conclusions The groups with sustained treatment and switching included patients with different disease activity status, although higher disease activity was determined in switchers. Overall, moderate disease activity and remission were the most common disease activity levels. Lower disease activity scores, lower hematologic manifestations, better functional status, and lesser radiographic damage are associated with sustained treatment. Turkish Medicine and Medical Devices Agency ; Ankara Numune Egitim ve Arastirma Hastanesi
- Published
- 2022
5. Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi-center study
- Author
-
Kemal Nas, Nihan Cuzdan, Hatice Bodur, Cevriye Mülkoğlu, İbrahim Tekeoğlu, Murat Toprak, Yaşar Keskin, Ayhan Kamanli, Sami Hizmetli, Fikriye Figen Ayhan, Mustafa Çaliş, Ajda Bal, Nesrin Şen, Hatice Reşorlu, Kevser Gok, Gizem Cengiz, Tiraje Tuncer, Yildiray Aydin, Sena Tolu, Erhan Capkin, Oznur Kutluk, Meltem Alkan Melikoglu, Betul Sargin, Gul Devrimsel, Ilknur Albayrak Gezer, Mehmet Tuncay Duruöz, İsmihan Sunar, Ömer Faruk Şendur, Ozan Volkan Yurdakul, Sevtap Acer Kasman, Hakan Alkan, Dilek Keskin, Erkan Kilic, Okan Küçükakkaş, Nilay Sahin, Hilal Ecesoy, and KÜÇÜKAKKAŞ, OKAN
- Subjects
Male ,obese patient ,cholesterol blood level ,Anxiety ,Hospital Anxiety and Depression Scale ,functional status ,people by smoking status ,Severity of Illness Index ,low density lipoprotein cholesterol ,Psoriasis Area and Severity Index ,Quality of life ,high density lipoprotein cholesterol ,Surveys and Questionnaires ,Health Assessment Questionnaire ,Immunology and Allergy ,Hospital Anxiety and Depression Scale-Anxiety ,BASDAI ,Fatigue ,C reactive protein ,Depression ,adult ,clinical trial ,female ,C-Reactive Protein ,Hospital Anxiety and Depression Scale-Depression ,triacylglycerol ,medicine.medical_specialty ,a multi‑center study.-, Rheumatology international, 2021 [Gok K., Nas K., Tekeoglu I., Sunar I., Keskin Y., Kilic E., Sargin B., Acer Kasman S., Alkan H., Sahin N., et al., -Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis] ,Immunology ,Psoriatic Arthritis ,Pain ,complication ,prostate specific antigen ,psychology ,Article ,Psoriatic arthritis ,Rheumatology ,Internal medicine ,ankylosing spondylitis ,medicine ,cross-sectional study ,DAS28 ,Humans ,Psoriasis ,controlled study ,Spondylitis, Ankylosing ,human ,Obesity ,Disease Activity ,Ankylosing spondylitis ,Functional Assessment of Chronic Illness Therapy ,psychological aspect ,business.industry ,questionnaire ,Arthritis, Psoriatic ,visual analog scale ,Prostate-Specific Antigen ,medicine.disease ,major clinical study ,body mass ,multicenter study ,Cross-Sectional Studies ,Bath ankylosing spondylitis functional index ,Quality of Life ,erythrocyte sedimentation rate ,BASFI ,business ,Body mass index - Abstract
This article aims to evaluate the possible effect of obesity on quality of life, psychological status, and other clinical variables in Psoriatic arthritis (PsA). PsA patients have been recruited by the Turkish League Against Rheumatism-Network from various centers in Turkey in this cross-sectional study. Patients with a body mass index (BMI) ? of 30 kg/m2 were considered obese. Differences among patients with regard to obesity status were assessed with health-related quality of life measures (PsA Quality of Life Questionnaire [PsAQoL]), psychological status (Hospital Anxiety and Depression Scale [HADS]), and disease activity parameters (the Disease Activity index for PSoriatic Arthritis [DAPSA], Disease Activity Score 28-C-reactive protein [DAS28-CRP], Bath Ankylosing Spondylitis Disease Activity Index [BASDAI], Psoriasis Area and Severity Index [PASI]), physical functions (Ankylosing Spondylitis Functional Index [BASFI], Health Assessment Questionnaire [HAQ], and Health Assessment Questionnaire for the spondyloarthropathies [HAQ-S]). Pain was assessed using visual analog scale of pain (VAS-P), and fatigue was evaluated using visual analog scale of fatigue (VAS-F) and Functional Assessment of Chronic Illness Therapy (FACIT). A total of 1033 patients with PsA, 650 (62.9%) non-obese and 383 (37.1%) obese were included in the study. The PsAQoL, HADS-Anxiety, HADS-Depression, DAPSA, DAS28-CRP, BASDAI, BASFI, HAQ and HAQ-S scores of the obese group were higher than the non-obese group (p < 0.05). VAS-P and PASI scores were similar between group of patients with and without obesity. Obese patients had higher median scores of VAS-F and FACIT than non-obese patients (p < 0.05). Linear regression analysis showed that BMI affects the quality of life, depression, and disease activity. Consequently, obesity has significant associations with higher disease activity, lower QoL, risk of anxiety, depression, and fatigue. Therefore, obesity should also be taken into account in the management of PsA patients. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
- Published
- 2021
6. Clinical performance of rheumatoid arthritis impact of disease score: A real-life evidence from the multicenter nationwide registry BioStaR
- Author
-
İsmihan Sunar, Remzi Çevik, Hatice Bodur, Erhan Capkin, Hasan Fatih Çay, Ozgur Akgul, Ilker Yagci, Feride Gogus, Şebnem Ataman, Mehmet Tuncay Duruöz, Gülcan Gürer, Aylin Rezvani, Ayhan Kamanli, Fatma Gül Yurdakul, and Meltem Alkan Melikoglu
- Subjects
Adult ,medicine.medical_specialty ,RAID ,Immunology ,Rheumatoid Arthritis ,Disease ,Severity of Illness Index ,law.invention ,Arthritis, Rheumatoid ,Disability Evaluation ,Rheumatology ,Discriminatory Ability ,law ,Internal medicine ,Surveys and Questionnaires ,medicine ,Immunology and Allergy ,Humans ,Registries ,Aged ,business.industry ,The Rheumatoid Arthritis Impact of Disease (RAID) ,Construct Validity ,Clinical performance ,Construct validity ,Middle Aged ,medicine.disease ,Cross-Sectional Studies ,Rheumatoid arthritis ,Antirheumatic Agents ,Quality of Life ,Observational study ,business ,Antirheumatic drugs - Abstract
The rheumatoid arthritis impact of disease (RAID) score was developed as a patient-derived composite response index for the evaluation of the disease impact on cases with rheumatoid arthritis (RA). The aim of this study was to evaluate the psychometric properties and performance of RAID score in the real-life settings. Cases with RA from our multi-center, nationwide registry called Biologic and targeted Synthetic antirheumatic drugs Registry RA (BioStaR RA) were included in this cross-sectional observational study. Demographic data, disease duration, pain, patient's global assessment (PGA) and physician's global assessment (PhyGA) were recorded. DAS28-ESR, DAS28-CRP, the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) were assessed as disease activity evaluations. The health assessment questionnaire-disability index (HAQ-DI) and RAID were completed by all the participants. The construct validity was tested by the analysis of correlations between RAID score and scores of PGA, disease activity indexes and HAQ-DI. We also evaluated the discriminatory ability of RAID to distinguish patients with different levels of disease activity and disability and the cut-off values were calculated by ROC analysis. 585 cases with RA were included in this investigation. The RAID score was significantly positively correlated with PGA, all disease activity indexes and HAQ-DI (p < 0.001). The discriminatory ability of RAID score in different disease activity and disability groups was also demonstrated (p < 0.001). To estimate DAS28-ESR (remission/low + moderate + high), RAID score cut-off points were 2.88 (sensitivity 73%, specificity 62%), 3.23 (sensitivity 75%, specificity 60%) and 3.79 (sensitivity 74%, specificity 58%), respectively. Our study indicated that RAID was a reliable tool in daily clinical practice by presenting its correlations with disease activity and disability assessments and by showing its discriminatory ability in these parameters in the real-life experiences. Turkish League Against Rheumatism (TLAR)
- Published
- 2021
7. The Turkish League against rheumatism recommendations for the management of hand osteoarthritis under guidance of the current literature and 2018 European League against rheumatism recommendations
- Author
-
Banu Kuran, Tiraje Tuncer, Tuncay Duruöz, Dilek Keskin, İsmihan Sunar, Fitnat Dinçer, Ebru Umay, Fikriye Figen Ayhan, Nazim Karalezli, Lale Altan, Bursa Uludağ Üniversitesi/Tıp Fakültesi/Fizik Tedavi ve Rehabilitasyon Anabilim Dalı/Romatoloji Anabilim Dalı., Altan, Lale, AAH-1652-2021, MÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, and Karalezli, Nazım
- Subjects
Splinting ,Turkish ,Self care ,Guideline ,Arthroscopy ,0302 clinical medicine ,Prevalance ,Randomized controlled trial (topic) ,Prevalence ,Medicine ,030212 general & internal medicine ,Disease activity ,Transcutaneous electrical nerve stimulation ,Progression ,Management ,Paraffin ,language ,Original Article ,Delphi round ,Human ,Quality of life ,medicine.medical_specialty ,Practice guideline ,Efficacy ,League ,Guidelines ,Article ,Arthroplasty ,03 medical and health sciences ,Osteoarthritis ,Thumb ,Carpometacarpal Joints ,Rheumatology ,Hand osteoarthritis ,Hand function ,Health care personnel ,Exercise ,Shared decision-making ,030203 arthritis & rheumatology ,Hip ,business.industry ,Muscle strength ,Optimal treatment ,Significant difference ,medicine.disease ,Hand ,language.human_language ,Nonsteroid antiinflammatory agent ,Delphi study ,Treatment ,Family medicine ,Systematic review ,Rheumatic disease ,business ,Rheumatism - Abstract
WOS: 000574427300001 Objectives: This study aims to explore the accordance to the 2018 European League Against Rheumatism (EULAR) recommendations for the management of hand osteoarthritis (OA) among the Turkish League Against Rheumatism (TLAR) expert panel and composition of TLAR recommendations for the management of hand OA under guidance of the current literature. Materials and methods: The TLAR convener designated an expert panel of 10 physicians experienced in hand OA for this process. The 2018 EULAR recommendations for the management of hand OA and the systematic review of the literature were sent to the expert panel via e-mails. The e-mail process which included Delphi round surveys was completed. The EULAR standard operational procedure Appraisal of Guidelines for Research and Evaluation II was followed. The level of agreement was calculated for each item and presented as mean, standard deviations, minimum and maximum and comparisons of 2018 EULAR recommendations were performed. Results: Five overarching principles and 10 recommendations were discussed. Revisions were held for the sixth, seventh, and ninth recommendations with lowest level of agreements. These recommendations were revised in accordance with suggestions from the experts and re-voted. The revised forms were approved despite the lack of statistically significant difference between these forms (p=0.400, p=0.451, p=0.496, respectively). Except for the ninth recommendation about surgery (p=0.008), no significant difference in level of agreements was observed between the EULAR and TLAR hand OA recommendations. The 11th recommendation about paraffin bath was added. Conclusion: The optimal treatment of hand OA consists of personalized non-pharmacological (self-management, exercise, splint), pharmacological (topical non-steroidal anti-inflammatory drugs as the first choke), and interventional procedures (only for refractory cases) based on shared decision between the patient and physician. TLAR hand OA recommendations were created mainly based on the most recent literature and the last EULAR hand OA management recommendations, which are widely approved among the TLAR experts.
- Published
- 2020
8. Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?
- Author
-
Rabia Tural, Ali Erhan Özdemirel, Şebnem Ataman, Aylin Sepici Dinçel, Duygu Tecer, Orhan Küçükşahin, and İsmihan Sunar
- Subjects
Male ,lcsh:Diseases of the musculoskeletal system ,030204 cardiovascular system & hematology ,Gastroenterology ,Carotid Intima-Media Thickness ,0302 clinical medicine ,Ca-LDL ,Homeostasis ,Carotid intima-media thickness ,Anti-Inflammatory Agents, Non-Steroidal ,Middle Aged ,Lipoproteins, LDL ,Antirheumatic Agents ,Psoriatic arthritis ,cardiovascular system ,Female ,Lipoproteins, HDL ,Leflunomide ,lcsh:Immunologic diseases. Allergy ,Risk ,medicine.medical_specialty ,Statistics, Nonparametric ,03 medical and health sciences ,Insulin resistance ,Rheumatology ,Internal medicine ,Statistical significance ,medicine ,Humans ,Serum amyloid A ,cardiovascular diseases ,Triglycerides ,030203 arthritis & rheumatology ,business.industry ,Arthritis, Psoriatic ,medicine.disease ,Atherosclerosis ,Methotrexate ,Subclinical atherosclerosis ,Case-Control Studies ,Tumor Necrosis Factor Inhibitors ,Atherogenic indexes ,lcsh:RC925-935 ,Insulin Resistance ,business ,lcsh:RC581-607 ,Body mass index ,Biomarkers ,Lipoprotein - Abstract
Background To investigate the link between carbamylated low-density lipoprotein (ca-LDL), atherogenic index of plasma (AIP), atherogenic coefficient (AC), Castelli’s risk indices I and II (CRI I and II) and subclinic atherosclerosis in psoriatic arthritis (PsA). Methods Thirty-ninepatients and 19 age, sex, body mass index matched healthy controls were included. Insulin resistance (IR) was assessed with homeostasis of model assessment-IR (HOMA-IR). Carotid intima-media thickness (CIMT) was measured at both common carotid arteries and mean CIMT was calculated. Results The mean age was 49.50 ± 11.86 years and 64.1% were females in PsA group. In the PsA group, CIMT and HOMA-IR were significantly higher (p = 0.003, p = 0.043, respectively). AIP, AC, TG/HDL, CRI-1, CRI-2 and ca-LDL levels were similar between groups. In PsA group, CIMT was positively correlated with HOMA-IR, TG/HDL and AIP. Although ca-LDL was positively correlated with serum amyloid A (r = 0.744, p r = 0.215, p = 0.195). PsA patients with IR tended to have higher ca-LDL levels than patients without IR, but this difference lacked statistical significance (33.65 ± 26.94, 28.63 ± 28.06, respectively, p = 0.237). Conclusions A significant increase in CIMT was seen in PsA patients without clinically evident cardiovascular disease or any traditional atherosclerosis risk factors. CIMT was correlated with HOMA-IR, TG/HDL and AIP.
- Published
- 2019
9. Turkish League Against Rheumatism Consensus Report: Recommendations For Management of Axial Spondyloarthritis
- Author
-
Cahit Kaçar, Fatma Gül Yurdakul, Fikriye Figen Ayhan, Erhan Capkin, Gürkan Yılmaz, Tuncay Duruöz, Murat Birtane, Ilhan Sezer, İsmihan Sunar, Yeşim Garip, Hilal Kocabas, Ömer Kuru, Sumru Özel, Hatice Bodur, Ozgur Akgul, Aylin Rezvani, Kemal Nas, Erhan Özdemirel, Gülcan Gürer, Meltem Alkan Melikoğlu, Remzi Çevik, Taciser Kaya, Ayhan Kamanli, Ayşen Akıncı, Ece Kaptanoğlu, Şebnem Ataman, Derya Buğdayci, Zuhal Altay, Hitit Üniversitesi, Hatice Bodur: 0000-0003-3008-7007, Şebnem Ataman: 0000-0003-3570-3825, Kemal Nas: 0000-0002-5845-085, Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Dahili Tıp Bilimleri, Fizik Tedavi ve Rehabilitasyon Anabilim Dalı, Sivas Cumhuriyet Üniversitesi, Department of Physical Medicine and Rehabilitation, Yıldırım Beyazıt University School of Medicine, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, SBÜ Ankara Numune Training and Research Hospital, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Ankara University School of Medicine, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, Sakarya University School of Medicine, Sakarya, Turkey, Department of Physical Therapy and Rehabilitation, School of Health Sciences, Uşak University, Uşak, Turkey, Department of Physical Medicine and Rehabilitation, Ankara Training and Research Hospital, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Celal Bayar University School of Medicine, Manisa, Turkey, Department of Physical Medicine and Rehabilitation, Hacettepe University School of Medicine, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, İnönü University School of Medicine, Malatya, Turkey, Department of Physical Medicine and Rehabilitation, Trakya University School of Medicine, Edirne, Turkey, Department of Physical Medicine and Rehabilitation, SBÜ İstanbul Training and Research Hospital, İstanbul, Turkey, Department of Physical Medicine and Rehabilitation, Karadeniz Teknik University School of Medicine, Trabzon, Turkey, Department of Physical Medicine and Rehabilitation, Dicle University School of Medicine, Diyarbakir, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Marmara University School of Medicine, İstanbul, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Adnan Menderes University School of Medicine, Aydın, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Akdeniz University School of Medicine, Antalya, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Sakarya University School of Medicine, Sakarya, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Sivas Cumhuriyet University School of Medicine, Sivas, Turkey, Department of Physical Medicine and Rehabilitation, SBÜ İzmir Bozyaka Training and Research Hospital, İzmir, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Ondokuz Mayıs University School of Medicine, Samsun, Turkey, Department of Physical Medicine and Rehabilitation, Divition of Rheumatology, Atatürk University School of Medicine, Erzurum, Turkey, Department of Rheumatology, SBÜ Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, Hitit University School of Medicine, Çorum, Turkey, Department of Physical Medicine and Rehabilitation, Bezmialem University School of Medicine, İstanbul, Turkey, Department of Physical Medicine and Rehabilitation, SBÜ Antalya Training and Research Hospital, Antalya, Turkey, Uşak Üniversitesi, [Bodur, Hatice -- Nas, Kemal] Yildirim Beyazit Univ, Dept Phys Med & Rehabil, Sch Med, Ankara, Turkey -- [Yurdakul, Fatma Gul -- Garip, Yesim] SBU Ankara Numune Training & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey -- [Ataman, Sebnem -- Sunar, Ismihan -- Yilmaz, Gurkan] Ankara Univ, Div Rheumatol, Dept Phys Med & Rehabil, Sch Med, Ankara, Turkey -- [Nas, Kemal] Sakarya Univ, Dept Phys Med & Rehabil, Sch Med, Sakarya, Turkey -- [Ayhan, Fikriye Figen] Usak Univ, Sch Hlth Sci, Dept Phys Therapy & Rehabil, Usak, Turkey -- [Ayhan, Fikriye Figen] Ankara Numune Training & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey -- [Akgul, Ozgur] Celal Bayar Univ, Div Rheumatol, Dept Phys Med & Rehabil, Sch Med, Manisa, Turkey -- [Akinci, Aysen] Hacettepe Univ, Dept Phys Med & Rehabil, Sch Med, Ankara, Turkey -- [Altay, Zuhal] Inonu Univ, Dept Phys Med & Rehabil, Sch Med, Malatya, Turkey -- [Birtane, Murat] Trakya Univ, Dept Phys Med & Rehabil, Sch Med, Edirne, Turkey -- [Soy Bugdayci, Derya] SBU Istanbul Training & Res Hosp, Dept Phys Med & Rehabil, Istanbul, Turkey -- [Capkin, Erhan] Karadeniz Tech Univ, Dept Phys Med & Rehabil, Sch Med, Trabzon, Turkey -- [Cevik, Remzi] Dicle Univ, Dept Phys Med & Rehabil, Sch Med, Diyarbakir, Turkey -- [Duruoz, Tuncay] Marmara Univ, Sch Med, Div Rheumatol, Dept Phys Med & Rehabil, Istanbul, Turkey -- [Gurer, Gulcan] Adnan Menderes Univ, Sch Med, Div Rheumatol, Dept Phys Med & Rehabil, Aydin, Turkey -- [Kacar, Cahit] Akdeniz Univ, Sch Med, Div Rheumatol, Dept Phys Med & Rehabil, Antalya, Turkey -- [Kamanli, Ayhan] Sakarya Univ, Sch Med, Div Rheumatol, Dept Phys Med & Rehabil, Sakarya, Turkey -- [Kaptanoglu, Ece] Sivas Cumhuriyet Univ, Sch Med, Div Rheumatol, Dept Phys Med & Rehabil, Sivas, Turkey -- [Kaya, Taciser] SBU Izmir Bozyaka Training & Res Hosp, Dept Phys Med & Rehabil, Izmir, Turkey -- [Kocabas, Hilal] Necmettin Erbakan Univ, Div Rheumatol, Meram Sch Med, Dept Phys Med & Rehabil, Konya, Turkey -- [Kuru, Omer] Ondokuz Mayis Univ, Div Rheumatol, Dept Phys Med & Rehabil, Sch Med, Samsun, Turkey -- [Melikoglu, Meltem Alkan] Ataturk Univ, Sch Med, Div Rheumatol, Dept Phys Med & Rehabil, Erzurum, Turkey -- [Ozdemirel, Erhan] SBU Diskapi Yildirim Beyazit Training & Res Hosp, Dept Rheumatol, Ankara, Turkey -- [Ozel, Sumru] Hitit Univ, Sch Med, Dept Phys Med & Rehabil, Corum, Turkey -- [Rezvani, Aylin] Bezmialem Univ, Sch Med, Dept Phys Med & Rehabil, Istanbul, Turkey -- [Sezer, Ilhan] SBU Antalya Training & Res Hosp, Dept Phys Med & Rehabil, Antalya, Turkey, Melikoglu, Meltem Alkan -- 0000-0001-7519-9470, OMÜ, Hitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, and Fiziksel Tıp ve Rehabilitasyon
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Turkish ,Delphi method ,League ,Nonpharmacological Management ,comorbidities ,Article ,Scientific evidence ,Comorbidities ,03 medical and health sciences ,Rheumatology ,medicine ,Axial spondyloarthritis ,treatment ,business.industry ,Exercises ,medicine.disease ,language.human_language ,exercises ,nonpharmacological management ,Clinical Practice ,Treatment ,030104 developmental biology ,Systematic review ,Family medicine ,language ,business ,Romatoloji ,Rheumatism ,Axial Spondyloarthritis - Abstract
WOS: 000429930000001, PubMed ID: 29900976, Objectives: This study aims to update 2011 Turkish League Against Rheumatism SpondyloArthritis Recommendations, and to compose a national expert opinion on management of axial spondyloarthritis under guidance of current guidelines, and implantation and dissemination of these international guidelines into our clinical practice. Materials and methods: A scientific committee of 28 experts consisting of 14 rheumatologists and 14 physical medicine and rehabilitation specialists (one of them also has an immunology PhD) was formed. The recommendations, systematic reviews, and meta-analyses including pharmacologic and non-pharmacologic treatment were scrutinized paying special attention with convenient key words. The draft of Turkish League Against Rheumatism opinion whose roof consisted of international treatment recommendations, particularly the Assessment of SpondyloArthritis International Society/European League Against Rheumatism recommendations was composed. Assessment of level of agreement with opinions by task force members was established through the Delphi technique. Voting using a numerical rating scale assessed the strength of each recommendation. Results: Panel compromised on five basic principles and 13 recommendations including pharmacological and nonpharmacological methods. All of the recommendations had adequate strength. Conclusion: Turkish League Against Rheumatism expert opinion for the management of axial spondyloArthritis was developed based on scientific evidence. These recommendations will be updated regularly in accordance with current developments.
- Published
- 2018
10. Management of psoriatic arthritis: Turkish League Against Rheumatism (TLAR) expert opinions
- Author
-
Tuncay Duruöz, Hatice Bodur, Zuhal Altay, Feride Gogus, Taciser Kaya, Ece Kaptanoğlu, Şebnem Ataman, Erhan Özdemirel, Gülcan Gürer, Erkan Kilic, Erhan Capkin, Ayşen Akıncı, Remzi Çevik, Ilhan Sezer, İsmihan Sunar, Ayhan Kamanli, Yeşim Garip, Ozgur Akgul, Hilal Kocabas, Kemal Nas, Abdullah Dagli, Sumru Özel, Cahit Kaçar, Figen Ayhan, Gürkan Yılmaz, Uşak Üniversitesi, Hitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Sivas Cumhuriyet Üniversitesi, Hitit Üniversitesi, [Nas, Kemal] Sakarya Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol & Immunol, Sakarya, Turkey -- [Kilic, Erkan] Afyonkarahisar State Hosp, Rheumatol Clin, Afyon, Turkey -- [Cevik, Remzi] Dicle Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Diyarbakir, Turkey -- [Bodur, Hatice] Yildirim Beyazit Univ, Sch Med, Dept Phys Med & Rehabil, Ankara, Turkey -- [Ataman, Sebnem -- Sunar, Ismihan -- Yilmaz, Gurkan] Ankara Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Ankara, Turkey -- [Ayhan, Figen] Usak Univ, Sch Hlth Sci, Dept Phys Therapy & Rehabil, Usak, Turkey -- [Ayhan, Figen] Ankara Numune Training & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey -- [Akgul, Ozgur] Celal Bayar Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Manisa, Turkey -- [Akinci, Aysen] Hacettepe Univ, Sch Med, Dept Phys Med & Rehabil, Ankara, Turkey -- [Altay, Zuhal] Inonu Univ, Sch Med, Dept Phys Med & Rehabil, Malatya, Turkey -- [Capkin, Erhan] Karadeniz Tech Univ, Sch Med, Dept Phys Med & Rehabil, Trabzon, Turkey -- [Dagli, Abdullah Zubeyir] Bitlis State Hosp, Phys Med & Rehabil Clin, Bitlis, Turkey -- [Duruoz, Tuncay] Marmara Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Istanbul, Turkey -- [Gurer, Gulcan] Adnan Menderes Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Aydin, Turkey -- [Gogus, Feride] Gazi Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Ankara, Turkey -- [Garip, Yesim] Ankara Numune Training & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey -- [Kacar, Cahit] Akdeniz Univ, Sch Med, Dept Phys Med & Rehabil, Antalya, Turkey -- [Kamanli, Ayhan] Sakarya Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Sakarya, Turkey -- [Kaptanoglu, Ece] Cumhuriyet Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Sivas, Turkey -- [Kaya, Taciser] Izmir Bozyaka Training & Res Hosp, Dept Phys Med & Rehabil, Izmir, Turkey -- [Kocabas, Hilal] Necmettin Erbakan Univ, Meram Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, Konya, Turkey -- [Ozdemirel, Erhan Ali] Hlth Sci Univ, Ankara Diskapi Training & Res Hosp, Dept Rheumatol Clin, Ankara, Turkey -- [Ozel, Sumru] Hitit Univ, Sch Med, Dept Phys Med & Rehabil, Corum, Turkey -- [Sezer, Ilhan] Hlth Sci Univ, Antalya Training & Res Hosp, Dept Phys Med & Rehabil, Antalya, Turkey, Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Dahili Tıp Bilimleri, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Department of Physical Medicine and Rehabilitation, Division of Rheumatology and Immunology, Sakarya University School of Medicine, Sakarya, Turkey, Rheumatology Clinic, Afyonkarahisar State Hospital, Afyon, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Dicle University School of Medicine, Diyarbakır, Turkey, Department of Physical Medicine and Rehabilitation, Yıldırım Beyazıt University School of Medicine, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Ankara University School of Medicine, Ankara, Turkey, Department of Physical Therapy and Rehabilitation, School of Health Sciences, Uşak University, Uşak, Turkey, Department of Physical Medicine and Rehabilitation, Ankara Training and Research Hospital, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Celal Bayar University School of Medicine, Manisa, Turkey, Department of Physical Medicine and Rehabilitation, Hacettepe University School of Medicine, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, İnönü University School of Medicine, Malatya, Turkey, Department of Physical Medicine and Rehabilitation, Karadeniz Technical University School of Medicine, Trabzon, Turkey, Physical Medicine and Rehabilitation Clinic, Bitlis State Hospital, Bitlis, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Marmara University School of Medicine, İstanbul, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Adnan Menderes University School of Medicine, Aydın, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Gazi University School of Medicine, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, Ankara Numune Training and Research Hospital, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Akdeniz University School of Medicine, Antalya, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Sakarya University School of Medicine, Sakarya, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Cumhuriyet University School of Medicine, Sivas, Turkey, Department of Physical Medicine and Rehabilitation, İzmir Bozyaka Training and Research Hospital, İzmir, Turkey, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey, Department of Rheumatology Clinic, Health Sciences University, Ankara Dışkapı Training and Research Hospital, Ankara, Turkey, Department of Physical Medicine and Rehabilitation, Hitit University School of Medicine, Çorum, Turkey, Department of Physical Medicine and Rehabilitation, Health Sciences University, Antalya Training and Research Hospital, Antalya, Turkey, and Fiziksel Tıp ve Rehabilitasyon
- Subjects
medicine.medical_specialty ,treatment recommendation ,Turkish ,League ,urologic and male genital diseases ,Expert committee ,Article ,03 medical and health sciences ,Psoriatic arthritis ,0302 clinical medicine ,Rheumatology ,medicine ,Turkish League Against Rheumatism ,Routine clinical practice ,030212 general & internal medicine ,030203 arthritis & rheumatology ,psoriatic arthritis ,business.industry ,Evidence-based medicine ,medicine.disease ,language.human_language ,Management ,Systematic review ,Family medicine ,Expert opinions ,language ,business ,Romatoloji ,Treatment recommendation ,Rheumatism ,management - Abstract
WOS:000435672000002, PubMed ID: 30207576, Objectives: This study aims to establish the first national treatment recommendations by the Turkish League Against Rheumatism (TLAR) for psoriatic arthritis (PsA) based on the current evidence. Materials and methods: A systematic literature review was performed regarding the management of PsA. The TLAR expert committee consisted of 13 rheumatologists and 12 physical medicine and rehabilitation specialists experienced in the treatment and care of patients with PsA from 22 centers. The TLAR recommendations were built on those of European League Against Rheumatism (EULAR) 2015. Levels of evidence and agreement were determined. Results: Recommendations included five overarching principles and 13 recommendations covering therapies for PsA, particularly focusing on musculoskeletal involvement. Level of agreement was greater than eight for each item. Conclusion: This is the first paper that summarizes the recommendations of TLAR as regards the treatment of PsA. We believe that this paper provides Turkish physicians dealing with PsA patients a practical guide in their routine clinical practice.
- Published
- 2018
11. Turkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: Expert Opinion of TLAR
- Author
-
Hilal Kocabas, Şebnem Ataman, Mehmet Tuncay Duruöz, Rezzan Günaydin, Derya Buğdayci, Aylin Rezvani, Lale Cerrahoğlu, Cahit Kaçar, Lale Altan, Ömer Faruk Şendur, Nesrin Şen, Gülcan Gürer, Hatice Bodur, Zuhal Altay, Ozgur Akgul, Figen Ayhan, Erhan Özdemirel, Zafer Günendi, Kemal Nas, Peyman Yalçin, Zühre Sari Sürmeli, Nurdan Kotevoğlu, Ece Kaptanoğlu, Taciser Kaya, Ajda Bal, Ayşen Akıncı, İsmihan Sunar, Erhan Capkin, Murat Birtane, Sivas Cumhuriyet Üniversitesi, Fiziksel Tıp ve Rehabilitasyon, Hilal Kocabaş: 0000-0002-3309-2998, NEÜ, Meram Tıp Fakültesi, Dahili Tıp Bilimleri, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, [Ataman, Sebnem -- Surmeli, Zuhre Sari -- Sunar, Ismihan -- Ozdemirel, Erhan -- Yalcin, Peyman] Ankara Univ, Fac Med, Div Rheumatol, Dept Phys Med & Rehabil, TR-06100 Ankara, Turkey -- [Akinci, Aysen] Hacettepe Univ, Fac Med, Dept Phys Med & Rehabil, TR-06100 Ankara, Turkey -- [Bodur, Hatice] Ankara Numune Training & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey -- [Akgul, Ozgur -- Cerrahoglu, Lale] Celal Bayar Univ, Fac Med, Dept Phys Med & Rehabil, Manisa, Turkey -- [Altan, Lale] Uludag Univ, Fac Med, Dept Phys Med & Rehabil, Bursa, Turkey -- [Altay, Zuhal] Inonu Univ, Fac Med, Dept Phys Med & Rehabil, Malatya, Turkey -- [Ayhan, Figen] Ankara Numune Training & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey -- [Birtane, Murat] Trakya Univ, Fac Med, Dept Phys Med & Rehabil, Edirne, Turkey -- [Soy Bugdayci, Derya] Istanbul Phys Med & Rehabil Training & Res Hosp, Dept Phys Med & Rehabil, Istanbul, Turkey -- [Capkin, Erhan] Karadeniz Tech Univ, Fac Med, Dept Phys Med & Rehabil, Trabzon, Turkey -- [Duruoz, Mehmet Tuncay] Marmara Univ, Fac Med, Dept Phys Med & Rehabil, Istanbul, Turkey -- [Gunaydin, Rezzan] Ordu Univ, Fac Med, Dept Phys Med & Rehabil, Ordu, Turkey -- [Gunendi, Zafer] Gazi Univ, Fac Med, Dept Phys Med & Rehabil, Ankara, Turkey -- [Gurer, Gulcan -- Sendur, Omer Faruk] Adnan Menderes Univ, Fac Med, Dept Phys Med & Rehabil, Aydin, Turkey -- [Bal, Ajda] Diskapi Training & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey -- [Kacar, Cahit] Akdeniz Univ, Fac Med, Dept Phys Med & Rehabil, TR-07058 Antalya, Turkey -- [Kaptanoglu, Ece] Cumhuriyet Univ, Fac Med, Dept Phys Med & Rehabil, Sivas, Turkey -- [Kaya, Taciser] Izmir Bozyaka Training & Res Hosp, Dept Phys Med & Rehabil, Izmir, Turkey -- [Kocabas, Hilal] Necmettin Erbakan Univ, Meram Fac Med, Dept Phys Med & Rehabil, Konya, Turkey -- [Kotevoglu, Nurdan] Maltepe Univ, Fac Med, Dept Phys Med & Rehabil, Istanbul, Turkey -- [Nas, Kemal] Sakarya Univ, Fac Med, Dept Phys Med & Rehabil, Adapazari, Turkey -- [Rezvani, Aylin] Bezmialem Vakif Univ, Fac Med, Dept Phys Med & Rehabil, Istanbul, Turkey -- [Sen, Nesrin] Elazig Training & Res Hosp, Dept Phys Med & Rehabil, Elazig, Turkey, kacar, cahit -- 0000-0002-1632-1621, Duruoz, Mehmet Tuncay -- 0000-0003-3584-2788, Ataman, S, Surmeli, ZS, Sunar, I, Ozdemirel, E, Akinci, A, Bodur, H, Akgul, O, Altan, L, Altay, Z, Ayhan, F, Birtane, M, Soy Bugdayci, D, Capkin, E, Cerrahoglu, L, Duruoz, MT, Gunaydin, R, Gunendi, Z, Gurer, G, Bal, A, Kacar, C, Kaptanoglu, E, Kaya, T, Kocabas, H, Kotevoglu, N, Nas, K, Rezvani, A, Sen, N, Sendur, OF, Yalcin, P, Maltepe Üniversitesi, and REZVANİ, AYLİN
- Subjects
rheumatoid arthritis ,medicine.medical_specialty ,congenital, hereditary, and neonatal diseases and abnormalities ,Turkish ,Alternative medicine ,League ,Treatment eecommendations ,behavioral disciplines and activities ,Synthetic disease modifying anti-rheumatic drugs ,Rheumatology ,Internal medicine ,medicine ,Rheumatoid arthritis ,synthetic disease modifying anti-rheumatic drugs ,skin and connective tissue diseases ,Tofacitinib ,business.industry ,social sciences ,Expert Opinion of TLAR-, ARCHIVES OF RHEUMATOLOGY, cilt.30, ss.271-284, 2015 [Ataman S., Surmeli Z. S. , Sunar I., Ozdemirel E., AKINCI A., Bodur H., AKGÜL Ö., ALTAN İNCEOĞLU L., ALTAY Z., Ayhan F., et al., -Turkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs] ,medicine.disease ,language.human_language ,eye diseases ,Test (assessment) ,Biologic disease modifying anti-rheumatic drugs ,treatment recommendations ,language ,Physical therapy ,population characteristics ,business ,Romatoloji ,Rheumatism ,geographic locations - Abstract
WOS:000366027100001, Objectives: This study aims to report Turkish League Against Rheumatisms assessment on the compliance of European League Against Rheumatism 2013 treatment recommendations for rheumatoid arthritis with practices in Turkish rheumatology clinics and adaptations for Turkey. Patients and methods: Members of Turkish League Against Rheumatism and one rheumatoid arthritis patient voted for the 2013 recommendations of the European League Against Rheumatism for treatment of rheumatoid arthritis in two sessions. An item was changed and voted again only if at least 70% of participants wanted a change. Strength of recommendations was calculated for the items. Strength of recommendations for the changed items in the first and second voting rounds was compared by Wilcoxon signed-rank test. In case of significant difference, the item with higher strength of recommendation was accepted. In case of no difference, the changed item was selected. Results: Three overarching principles and fourteen recommendations were assessed among which the three overarching principles were changed emphasizing the importance of physiatrists as well as rheumatologists for taking care of the patients. Third item was changed by adding composite indices for assessing disease activity. In the ninth recommendation, rituximab was suggested as a first line drug independent of situations like latent tuberculosis or lymphoma, etc. In the 11th recommendation, unlike European League Against Rheumatism, our committee did not suggest any thought about tofacitinib, as then it had not been approved in Turkey. Remaining principles were accepted as the same. Conclusion: Expert opinion of Turkish League Against Rheumatism for treatment of rheumatoid arthritis patients was formed for practices in Turkish clinics. Conflict of Interest The authors declared no conflicts of interest with respect to the authorship and/or publication of this article. Financial Disclosure The authors received no financial support for the research and/or authorship of this article.
- Published
- 2015
12. Turkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: Expert Opinion of TLAR
- Author
-
ŞEBNEM ATAMAN, Zühre SÜRMELİ SARI, İsmihan SUNAR, Erhan ÖZDEMİREL, Ayşen AKINCI, Hatice BODUR, ÖZGÜR AKGÜL, LALE ALTAN İNCEOĞLU, Zuhal ALTAY, Figen AYHAN, MURAT BİRTANE, Derya BUĞDAYCI SOY, Erhan ÇAPKIN, AYŞE BEYHAN LALE CERRAHOĞLU, MEHMET TUNCAY DURUÖZ, Rezzan GÜNAYDIN, ZAFER GÜNENDİ, Gülcan GÜRER, AJDA BAL HASTÜRK, Cahit KAÇAR, Ece KAPTANOĞLU, Taciser KAYA, Hilal KOCABAŞ, Nurdan KOTEVOĞLU, KEMAL NAS, Aylin REZVANİ, Nesrin ŞEN, ÖMER FARUK ŞENDUR, Peyman YALÇIN, Tanımlanmamış Kurum, ANKARA NUMUNE EĞİTİM VE ARAŞTIRMA HASTANESİ > ANKARA NUMUNE EĞİTİM VE ARAŞTIRMA HASTANESİ, FİZİKSEL TIP VE REHABİLİTASYON, CELÂL BAYAR ÜNİVERSİTESİ, İNÖNÜ ÜNİVERSİTESİ, ANKARA EĞİTİM VE ARAŞTIRMA HASTANESİ > ANKARA EĞİTİM VE ARAŞTIRMA HASTANESİ, FİZİKSEL TIP VE REHABİLİTASYON, MARMARA ÜNİVERSİTESİ, GAZİ ÜNİVERSİTESİ, ANKARA DIŞKAPI YILDIRIM BEYAZIT EĞİTİM VE ARAŞTIRMA HASTANESİ > ANKARA DIŞKAPI YILDIRIM BEYAZIT EĞİTİM VE ARAŞTIRMA HASTANESİ, FİZİKSEL TIP VE REHABİLİTASYON, CUMHURİYET ÜNİVERSİTESİ, and MALTEPE ÜNİVERSİTESİ
- Subjects
skin and connective tissue diseases ,behavioral disciplines and activities - Abstract
Objectives: This study aims to report Turkish League Against Rheumatism s assessment on the compliance of European League Against Rheumatism 2013 treatment recommendations for rheumatoid arthritis with practices in Turkish rheumatology clinics and adaptations for Turkey. Patients and methods: Members of Turkish League Against Rheumatism and one rheumatoid arthritis patient voted for the 2013 recommendations of the European League Against Rheumatism for treatment of rheumatoid arthritis in two sessions. An item was changed and voted again only if at least 70% of participants wanted a change. Strength of recommendations was calculated for the items. Strength of recommendations for the changed items in the first and second voting rounds was compared by Wilcoxon signed-rank test. In case of significant difference, the item with higher strength of recommendation was accepted. In case of no difference, the changed item was selected. Results: Three overarching principles and fourteen recommendations were assessed among which the three overarching principles were changed emphasizing the importance of physiatrists as well as rheumatologists for taking care of the patients. Third item was changed by adding composite indices for assessing disease activity. In the ninth recommendation, rituximab was suggested as a first line drug independent of situations like latent tuberculosis or lymphoma, etc. In the 11th recommendation, unlike European League Against Rheumatism, our committee did not suggest any thought about tofacitinib, as then it had not been approved in Turkey. Remaining principles were accepted as the same. Conclusion: Expert opinion of Turkish League Against Rheumatism for treatment of rheumatoid arthritis patients was formed for practices in Turkish clinics. Conflict of Interest The authors declared no conflicts of interest with respect to the authorship and/or publication of this article. Financial Disclosure The authors received no financial support for the research and/or authorship of this article.
- Published
- 2015
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.